PharmaCyte Biotech, Inc.
PMCB · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $8 | $11 | $14 |
| - Cash | $13 | $15 | $16 | $21 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6 | -$7 | -$5 | -$7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$8 | $12 | -$3 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.23 | 1.6 | -0.44 | -0.39 |
| % Growth | -176.9% | 463.6% | -12.8% | – |
| Operating Cash Flow | -$2 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$1 | -$1 |